Cargando…
Nonsteroidal anti-inflammatory drugs and glucocorticoids in COVID-19
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is characterized by a wide spectrum of symptom severity, which is manifested at different phases of infection and demands different levels of care. Viral load, host innate-immune response to...
Autores principales: | Ricciotti, Emanuela, Laudanski, Krzysztof, FitzGerald, Garret A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280659/ https://www.ncbi.nlm.nih.gov/pubmed/34303107 http://dx.doi.org/10.1016/j.jbior.2021.100818 |
Ejemplares similares
-
Traditional Nonsteroidal Anti-Inflammatory Drugs and Postmenopausal Hormone Therapy: A Drug–Drug Interaction?
por: García Rodríguez, Luis Alberto, et al.
Publicado: (2007) -
Modulation of the Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination by Nonsteroidal Anti-Inflammatory Drugs
por: Skarke, Carsten, et al.
Publicado: (2023) -
Nonsteroidal Anti-Inflammatory Drugs and the Kidney
por: Hörl, Walter H.
Publicado: (2010) -
Nonsteroidal anti‐inflammatory drugs and pharyngitis
por: Mazzone, Stuart B, et al.
Publicado: (2022) -
Topical nonsteroidal anti-inflammatory drugs
por: Bhat, Chirag, et al.
Publicado: (2023)